- Frouke M Engelaer, PhD student1,
- David van Bodegom, assistant professor of medicine at Leiden University Medical Centre1,
- Rudi G J Westendorp, professor of medicine at Leiden University Medical Centre1
- 1Leyden Academy on Vitality and Ageing, 2333 AA Leiden, Netherlands
The open label treatment extension of the original HYVET study received enthusiastic applause as further evidence for direct and long term benefits of treating hypertension in very old people (≥80 years).1 However, we should be cautious in extrapolating these findings to clinical practice.